https://www.cnbc.com/2023/11/17/rsv-cdc-expedites-release-of-sanofi-astrazeneca-drug-amid-shortage.html
The CDC's move to increase availability of Beyfortus, a monoclonal antibody from Sanofi and AstraZeneca, comes as RSV cases rise in some parts of the country.
Create an account or login to join the discussion